Categories: Wire Stories

Expert Seminar on Anti-COVID-19 Chinese Herbal Medicine �Honee Taishen Granule� Held in Ritan, Beijing

BEIJING–(BUSINESS WIRE)–On November 26, 2020, Beijing Handian Pharmaceutical held an expert seminar on anti-COVID-19 medicine �Honee Taishen Granule” in Ritan, Beijing.

At this meeting, the company invited a number of experts from the Chinese Academy of Sciences and the Chinese Academy of Medical Sciences to discuss the current research results of “Taishen Granules” and put forward their suggestions on the future research and development direction of this drug.

The company started a long-term anti-plague research program since Ebola outbreak in 2015, and Taishen Granule comes from a reserve formula of that program. This formula is derived from an ancient prescription against Taiyin cold-dampness and stagnation lung syndrome, which is consistent with symptoms of this COVID-19 epidemic according to traditional Chinese medicine theory. The company’s scientific research team combined with epidemiological research and clinical trial experience, followed the ancient prescription dosage and technology, and finally developed this drug.

Its components can eliminate dampness and turbidity, repel foulness and remove toxin, which give it cold-dampness eliminating and antiviral effects. According to traditional Chinese medicine theory, it rectifies Taiyin cold damp constitution and restores yin-yang balance of the body, which can help patients regain immunity and prevents the virus from affecting the spleen to damage the body.

In cooperation with the Chinese Academy of Medical Sciences, the Chinese Academy of Chinese Medical Sciences and Good Laboratory Practice (GLP) certification agencies, Handian Pharmaceutical research team has carried out relevant research on pharmacology and toxicology of this product. With the gradual improvement of various studies, it is hoped that the efficacy and safety of this product can be further verified.

Unfortunately, due to the lack of COVID-19 patients in China, it is difficult to carry out clinical research on this drug. As a result, the company is seeking international cooperation to provide antiviral drugs, and conduct further clinical research.

The Ritan (which means the Temple of Sun in Chinese) used to be a sacred place for ancient Chinese people to worship the God of Sun. The “Taishen Granule” expert seminar is held here in the hope that “Taishen Granule” will act like the sun to dispel the pain and darkness brought by COVID-19 to this world.

Contacts

Xiaoteng Bai

Beijing Handian Science & Technology (Group) Co., Ltd.

Phone: +86 010 5690 3502

Alex

Recent Posts

LambdaTest Enhances Security and Performance with SOCKS5 Proxy and HTTP/2 Support

LambdaTest Tunnel boosts its security and performance with SOCKS5 proxy and HTTP/2 support, enabling secure,…

3 hours ago

Win-Win Development and Common Future, 2024 Dongfeng Global Partners Summit Kicked Off

WUHAN, China--(BUSINESS WIRE)--With the acceleration of globalization, China automobile industry is facing new opportunities for…

3 hours ago

FOX News Media Names Diana Jachman and Nathaniel King as Recipients of Fifth Annual Dr. Charles Krauthammer Memorial Scholarship

NEW YORK--(BUSINESS WIRE)--FOX News Media, in partnership with the National Merit Scholarship Program, has selected…

3 hours ago

Shaperon to Conduct Strategic Partnering and Institutional Investor Meetings at the 10th Annual BFC Healthcare Business Development & Investment Conference in Shanghai

SHANGHAI & SEOUL, South Korea & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shaperon, Inc. (Kosdaq: 378800), a biotechnology company…

3 hours ago

CDB Aviation Purchases Four Airbus Aircraft from Avolon

Purchases Demonstrate Lessor’s Continued Strong Activity in Secondary Market DUBLIN--(BUSINESS WIRE)--#AndyCronin--CDB Aviation, a wholly owned…

5 hours ago

Makana™ Issued Patent in South Korea for Its Genetically-Modified TKO Pig for Use in Xenotransplantation

Company in discussions with U.S. Food and Drug Administration regarding first-ever human clinical trial as…

5 hours ago